v3.26.3
Equity-based Compensation (Tables)
9 Months Ended
Sep. 30, 2026
Equity-based Compensation  
Summary of activity for options

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Options Outstanding

​

​

​

​

​

​

​

​

Weighted-Average

​

​

​

​

​

​

Aggregate

​

Remaining

​

​

Number of

​

Weighted-Average

​

Intrinsic Value

​

Contractual Life

​

  ​ ​ ​

Options

  ​ ​ ​

Exercise Price

  ​ ​ ​

(in 000’s)

  ​ ​ ​

(In Years)

Balance, December 31, 2025

 

3,638,024

​

$

5.40

 

$

210

​

5.6

Options granted

 

—

​

​

—

​

​

​

​

​

Options exercised

 

(52,878)

​

​

0.84

​

​

​

​

​

Options forfeited

 

(1,388)

​

​

1.69

​

​

​

​

​

Options expired

 

(9,195)

​

​

1.76

​

​

​

​

​

Balance, September 30, 2026

 

3,574,563

​

$

5.48

​

$

1

​

4.9

Exercisable as of September 30, 2026

 

3,479,077

​

$

5.58

​

$

1

​

4.8

Schedule of restricted stock units award activity

​

​

​

​

​

​

​

​

​

Number of

​

Weighted-Average

​

​

Restricted Stock Units

​

Grant Date Fair Value

Outstanding at December 31, 2025

​

2,433,682

​

$

0.85

Granted

​

2,322,219

​

$

1.14

Vested

​

(756,849)

​

$

0.91

Forfeited

​

(269,875)

​

$

1.07

Outstanding at September 30, 2026

​

3,729,177

​

$

1.00

Schedule of total equity-based compensation expense

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended September 30, 

​

Nine Months Ended September 30, 

 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

 

Research and development

​

$

135

​

$

307

​

$

405

​

$

948

​

General and administrative

​

 

213

​

 

215

​

 

592

​

 

781

​

Total equity-based compensation

​

$

348

​

$

522

​

$

997

​

$

1,729

​